Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 14.59% | 0.98% | 0.98% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 14.59% | 0.98% | 0.98% |
Driehaus Small/Mid Cap Growth Strategy outperformed its benchmark by 450 basis points in Q1 2026, gaining 0.98% versus a 3.52% decline for the Russell 2500 Growth Index. The quarter was dominated by the Iran War which began February 28th, causing crude oil to nearly double from $65 to over $100 and creating significant market volatility. Despite this backdrop, the strategy benefited from strong positioning in AI-related technology hardware, industrial companies benefiting from grid upgrade capex, and energy holdings that surged on supply disruptions. Key contributors included semiconductors, optical equipment, and engineering & construction companies focused on electrical grid infrastructure. The strategy increased exposure to technology, industrials, and energy while reducing healthcare, consumer discretionary, and financials. Looking forward, the manager sees potential for strong market recovery if the fragile US-Iran ceasefire holds and the Strait of Hormuz reopens. Small cap valuations remain appealing with earnings expected to outgrow large caps, supported by multiple secular growth themes including AI infrastructure and energy transition.
Small/mid cap growth companies are positioned to benefit from multiple secular and cyclical growth drivers including AI infrastructure buildout, industrial capex cycles, and energy transition themes, while trading at appealing valuations relative to large caps with accelerating earnings growth.
The manager believes if the fog of war clears and the ceasefire proves sustainable, the market impact will be very positive. However, damaged Middle East energy infrastructure will continue to impact global supply. If peace prevails, the market will likely recover strongly. The macro data suggests the economy remains resilient and continues to grow nicely.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Apr 14 2026 | 2026 Q1 | COHR, CRS, FTAI, OWL, PRAX, TER | AI, defense, energy, growth, industrials, Iran, small caps, technology | - | Driehaus Small/Mid Cap Growth outperformed by 450bps in Q1 2026 despite Iran War volatility, benefiting from AI infrastructure, grid upgrade, and energy themes. Strategy positioned in tech hardware, industrials, and energy while avoiding disrupted sectors. Manager expects strong recovery if ceasefire holds and Strait of Hormuz reopens, with small caps offering compelling valuations and accelerating earnings. |
| Jan 14 2026 | 2025 Q4 | CRNX, CVNA, GH, NTRA, PWR, XBI | AI, Biotechnology, energy, growth, healthcare, industrials, small caps, technology | - | Small cap earnings are accelerating and expected to outgrow large caps through 2026, driving outperformance from April lows. AI dominance continues supporting economic expansion and capex spending. Healthcare strength from biotech approvals led Q4 gains. Despite software weakness and geopolitical risks, the 2026 outlook remains bullish given broadening market participation and favorable macro drivers supporting small cap momentum. |
| Oct 14 2025 | 2025 Q3 | ALAB, AXON, CVNA, GH, PWR | AI, Data centers, earnings, growth, healthcare, industrials, small cap, technology |
AXON US PWR US CVNA US GH US |
Driehaus Small/Mid Cap Growth delivered 10.74% in Q3 2025, benefiting from AI-driven economic transformation and small cap earnings acceleration. The strategy is overweight industrials and energy, capitalizing on hyperscaler capex and utility infrastructure spending. Fed easing provides tailwinds while small cap earnings are expected to outpace large caps through 2026. |
| Jul 11 2025 | 2025 Q2 | AXON, CVNA, CYBR, NTRA, PODD | AI, energy, growth, industrials, infrastructure, small cap, tariffs, technology | - | Strong Q2 outperformance driven by industrials and AI infrastructure recovery after tariff-induced volatility. Strategy increased exposure to data center buildout and nuclear infrastructure themes while reducing healthcare on regulatory concerns. Favorable outlook for second half assumes stable tariff policy with continued economic growth from AI productivity gains and fiscal stimulus. |
| Apr 17 2025 | 2025 Q1 | AXON, CVNA, CYBR, NTRA, SFM | AI, Biotechnology, growth, healthcare, small cap, tariffs, technology, Trade Policy | - | Strategy underperformed amid historic tariff-driven volatility and AI theme collapse. Trump's massive tariff announcement caused unprecedented selling before pivoting to 90-day pause. Healthcare allocation increased despite RFK Jr headwinds while reducing cyclical exposures. Outlook hinges on trade negotiations with potential market relief if tariff rates decline from current levels. |
| Jan 17 2025 | 2024 Q4 | CALX, FSLR, KNSL, PWR, WSC | Fed policy, growth, inflation, infrastructure, Onshoring, Recession, small cap, Valuations | - | Driehaus Small/Mid Cap Growth underperformed significantly in 2022's brutal market, but sees compelling opportunity as small caps trade at historically cheap valuations versus large caps. Strategy positioned for reshoring, infrastructure spending, and energy transition themes while maintaining overweight to industrials. Challenging macro conditions persist but current valuations offer attractive risk-reward for patient investors. |
| Oct 11 2024 | 2024 Q3 | AXON, CRNX, CYBR, HEI, TMDX | AI, Biotechnology, earnings, growth, healthcare, industrials, rates, small caps | - | Small/mid cap growth strategy positioned for outperformance as Fed cuts rates and small caps trade at historical valuation discounts. Strong year-to-date performance driven by AI infrastructure, reshoring, and biotech themes. Portfolio overweight industrials and healthcare while reducing technology exposure. Manager expects continued economic growth and earnings acceleration to support small cap outperformance versus large caps. |
| Jul 28 2024 | 2024 Q2 | AXON, CCJ, HEI, NTRA, ONTO | AI, Biotech, growth, healthcare, industrials, semiconductors, small cap, technology | - | Driehaus Small/Mid Cap Growth significantly outperformed in Q2 through strong stock selection, particularly in AI-benefiting semiconductors and biotech innovation. Manager increased tech exposure as fundamentals improved while maintaining industrial overweights for reshoring themes. With small caps at historic valuation discounts and Fed cuts likely, portfolio positioned for earnings recovery and economic stabilization in second half. |
| Apr 27 2024 | 2024 Q1 | NVDA, SMCI | AI, Data centers, energy, growth, industrials, semiconductors, small cap, technology | - | Driehaus Small/Mid Cap Growth significantly outperformed in Q1 2024, driven by AI infrastructure beneficiaries including Super Micro Computer and semiconductor holdings. The strategy capitalizes on early-stage AI adoption, reshoring trends, and improving small-cap earnings outlook. Portfolio emphasizes industrials and selective technology exposure while maintaining overweight positions in energy and consumer staples. |
| Jan 17 2024 | 2023 Q4 | CALX, FSLR, KNSL, PWR, WSC | Fed policy, growth, industrials, inflation, infrastructure, Onshoring, Recession, small cap | - | Small/mid cap growth strategy underperformed in brutal 2022 but manager sees opportunity in current uncertainty. Inflation drivers are normalizing while small caps trade at historically cheap valuations versus large caps. Portfolio emphasizes industrials benefiting from reshoring and infrastructure spending themes. Fed policy normalization should drive multiple expansion as recession fears are already discounted. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
AIAI continues to be the major theme driving performance across multiple market sectors. The market has separated companies into AI beneficiaries versus those disrupted by AI. AI compute demand continues to exceed supply, giving confidence to the sustainability of hyperscaler capex data center buildout. |
Data Centers Cloud Semiconductors Hardware Capex |
EnergyThe Iran War dramatically impacted crude oil prices as WTI increased from $65 to over $100. Energy infrastructure damage in the Persian Gulf disrupted supply of crude oil, natural gas, aluminum and petrochemicals. The Strait of Hormuz closure blocked 20% of world's crude oil from reaching global markets. |
Oil Natural Gas Geopolitical Supply Infrastructure | |
Grid UpgradeIndustrial companies are benefitting from the utility capex cycle driving an upgrade and expansion of the US electrical grid. An engineering & construction company focused on the electrical grid was a top performer with strong backlog growth and accelerating revenue. |
Utilities Infrastructure Spending Electrical Equipment Construction Capex | |
Private CreditGrowing stress in private credit markets with Blue Owl Capital at the epicenter of concerns due to elevated withdrawal requests. Credit crises often start as small cracks and grow larger than initially expected, with market watching for signs of contagion. |
Credit Stress BDC Alternative Asset Managers Liquidity Systemic Risk | |
DefenseDefense holdings performed well with outperformance driven by strong earnings and improving outlooks across commercial aerospace, defense, and satellite services. The Iran War context has heightened focus on defense-related investments. |
Defense Spending Aerospace Satellites Geopolitical Government | |
| 2025 Q4 |
AIAI developments from major companies are causing rapid market changes and stock price declines for quality businesses. The manager sees AI creating disruption across white collar work including finance, law, software development, and insurance. Software companies face particular headwinds from fewer seats, lower pricing power, and competition from AI-first upstarts. |
Artificial Intelligence Software Disruption White Collar Automation |
SoftwareSoftware companies are experiencing significant declines as the market reassesses AI impacts. The manager notes three vectors affecting valuations: fewer seats due to efficiency gains, lower pricing power from AI competition, and reduced new customer bookings. However, believes some software solutions won't be easily replaced and is reviewing opportunities in the wreckage. |
SaaS Enterprise Software Pricing Power Competition Valuation | |
| 2025 Q3 |
AIAI continues to be the dominant theme driving the market and economy. Over the intermediate and long-term profit margins should expand as companies become more productive and efficient by using AI. The biggest beneficiaries continue to be companies levered to the robust hyperscaler capex and data center buildout. |
Data Centers Hyperscaler Productivity Infrastructure Capex |
Data CentersHyperscaler capital expenditures are driving revenue and earnings growth for numerous companies. The portfolio holds strong fundamental companies that are levered to the data center buildout, including semis, optical equipment suppliers, contract manufacturers as well as emerging data center operators. |
Hyperscaler Capex Infrastructure Semiconductors Optical | |
Energy TransitionGrowing utility capex trend as energy demand from AI and data center growth is fueling a dramatic rise in electricity consumption. The portfolio saw strong gains in an emerging SMR (Small Modular Reactor) company, a geothermal provider, and an independent power producer. |
Utility Capex Electricity SMR Geothermal Nuclear | |
EarningsSmall cap earnings have surged recently and are accelerating, exceeding expectations by the largest amount since early 2022. Small cap earnings growth is now positive and expected to eclipse large cap earnings growth in 2H2025 and 2026. |
Small Cap Growth Expectations Acceleration Outperformance | |
| 2025 Q2 |
AIAI infrastructure demand remains robust with hyperscalers continuing competitive spending battle. DeepSeek concerns proved temporary as AI capex trends remain strong with new use cases driving productivity gains. The strategy increased exposure to AI data center buildout companies during the quarter. |
Data Centers Infrastructure Capex Hyperscalers Productivity |
Trade PolicyTrump's reciprocal tariffs caused severe market stress until 90-day pause announced April 9th. Market assumes 10% baseline tariffs with higher rates for countries with larger trade surpluses. Uncertainty continues as Trump threatens higher rates on key countries. |
Tariffs Trade Policy Uncertainty Economic | |
Infrastructure SpendingReshoring and infrastructure continue as sources of economic growth. Nuclear infrastructure, traditional infrastructure, and engineering & construction showed strength. AI data center buildout driving hundreds of billions in spending. |
Reshoring Nuclear Construction Growth Investment | |
Energy TransitionEnergy sector contributed positively with natural gas levered E&P companies and uranium mining exposure. Nuclear infrastructure showed strength as part of broader energy transition themes. |
Natural Gas Uranium Nuclear Mining Infrastructure | |
| 2025 Q1 |
Trade PolicyTrump announced reciprocal tariffs of at least 10% globally with rates up to 50% on 60 countries, causing extreme market volatility. After four days of sharp declines, Trump pivoted to a 90-day pause with 10% rates except China at 145%. The administration and trading partners are entering negotiations with potential for reduced tariff rates. |
Tariffs Trade Negotiations China Policy |
AIDeepSeek's debut of a lower cost Open Source AI Large Language Model on January 27th caused extreme selling in AI infrastructure stocks. The introduction effectively ended the AI infrastructure investment theme as concerns rose about sustainability of AI capex growth and potential commoditization of LLMs. |
DeepSeek Infrastructure Capex LLM Data Centers | |
BiotechnologyHealthcare sector saw widespread multiple compression due to RFK Jr's controversial appointment as HHS Secretary overseeing FDA. Despite market fears about drug approval processes, biotech management teams report normal FDA dialogue with no signs of slowdown. Portfolio holdings have promising clinical stage therapies in obesity, epilepsy, diabetes, neurology, autoimmune diseases, and oncology. |
FDA Drug Approval Clinical Trials RFK Jr Therapeutics | |
OnshoringManufacturing reshoring has been accelerating since Covid and is viewed as a sustainable multi-year theme. Trump wants to return manufacturing back to the U.S. after thousands of plants closed and millions of jobs disappeared following China's WTO entry in 2001. |
Manufacturing Reshoring Jobs WTO China | |
| 2024 Q4 |
InflationManager believes inflation will continue to fall as key drivers like excess money supply (M2 now negative year-over-year), excess savings, and supply chain issues have largely normalized. The Fed remains focused on labor market tightness and wage inflation as the primary remaining concern. |
Fed Policy Labor Markets Supply Chains Money Supply Wage Growth |
OnshoringReshoring is identified as a powerful trend reversing decades of overseas manufacturing due to Covid supply chain disruptions and uncertain behavior by China. This creates opportunities for US companies across multiple sub-industries including engineering, construction, and automation. |
Supply Chains Manufacturing China Automation Construction | |
Infrastructure SpendingMultiple federal stimulus programs worth over $1 trillion including new infrastructure spending, Inflation Reduction Act, Rural Broadband programs, and Chips Act offer significant opportunities for US companies across various sectors. |
Federal Spending Broadband Chips Act Clean Energy Construction | |
Energy TransitionThe portfolio maintains exposure to renewable and clean energy companies that should benefit from federal stimulus programs. Energy sector remains volatile but the manager sees opportunities in EV suppliers and specialty material companies. |
Renewables Electric Vehicles Clean Energy Federal Programs Materials | |
Small CapsSmall cap valuations are at historically cheap levels versus large caps, representing the second largest discount in 40 years. Current small cap valuations are at levels similar to past recessions, offering attractive opportunities despite challenging market conditions. |
Valuations Relative Performance Historical Discount Recession Levels Opportunity | |
| 2024 Q3 |
AIAI remains a powerful transformational theme with robust capex spending on data centers and infrastructure. Hyperscalers view AI as an existential threat to their business models and are increasing AI GPU cluster intelligence from current IQ levels of 100-120 to genius levels of 160+ and potentially 1,000. While 40% capex increases may decelerate in 2025-2026, AI infrastructure spending will remain strong. |
Data Centers Capex GPUs Infrastructure Hyperscalers |
OnshoringReshoring is identified as one of the major themes that has boosted the broader economy over the past few years, helping offset individual industry downturns. The portfolio benefits from positions exposed to attractive trends within reshoring, particularly in industrials. |
Manufacturing Supply Chain Industrials Infrastructure | |
Infrastructure SpendingInfrastructure is highlighted as a key theme supporting economic growth and portfolio positioning. The strategy maintains positions benefiting from infrastructure trends, particularly within the industrials sector which represents the largest absolute weight in the portfolio. |
Construction Industrials Government Spending Materials | |
BiotechnologyBiotech holdings have very promising and innovative clinical stage therapies demonstrating superior efficacy and safety in important disease indications including obesity, epilepsy, endocrinology, diabetes, neurology, autoimmune diseases, vaccines, and oncology. The portfolio anticipates promising results from upcoming clinical trials with biotech positions appreciating 15.1% versus 7.9% for the index. |
Clinical Trials Drug Development Oncology Vaccines Therapeutics | |
| 2024 Q2 |
AIPortfolio increased semiconductor exposure from 0.9% to 4.0% overweight as holdings benefited from AI infrastructure buildout. Semiconductor holdings appreciated 31.6% versus 5.0% for the index, driven by companies supplying data centers and AI hardware infrastructure. |
Data Centers Semiconductors Infrastructure Hardware |
SemiconductorsSemiconductor group contributed 130 basis points of outperformance as holdings appreciated 31.6% versus 5.0% for index. Portfolio increased exposure significantly as fundamental outlook for holdings and industry improved dramatically. |
Semi Equipment Components Foundries Memory | |
OnshoringReshoring remains a strong theme supporting industrial sector positioning. Portfolio maintains overweight to industrials at 25.4% versus 19.6% for index, benefiting from companies tied to reshoring trends. |
Manufacturing Supply Chain Domestic Production | |
BiotechnologyBiotech holdings demonstrate promising clinical stage therapies in obesity, epilepsy, endocrinology, diabetes, neurology, autoimmune diseases, vaccines, and oncology. Manager anticipates promising results from upcoming clinical trials. |
Clinical Trials Drug Development Therapeutics Pharmaceuticals | |
| 2024 Q1 |
AIAI holds tremendous potential to enhance productivity across industries through automation, analytics, and customer experience improvements. Enterprise adoption is still nascent but growing rapidly, with 45% piloting AI and only 10% in production. The manager views AI as early-stage with durable growth prospects, comparing it favorably to past technology cycles like the internet and cloud. |
Machine Learning Data Centers Productivity Enterprise Software Automation |
SemiconductorsSemiconductor companies have been among the strongest performers, with Nvidia becoming the third largest S&P 500 weighting and Super Micro Computer becoming the largest Russell 2000 weighting. The manager sees continued growth driven by AI infrastructure buildout and believes current valuations remain reasonable despite strong performance. |
AI Chips Hardware Nvidia Server Equipment Processing Power | |
Data CentersData center demand is expected to expand dramatically over the next five years, with CoreWeave describing daily requests as absurd. Nvidia's CEO expects over $250 billion annually in data center equipment spending, benefiting numerous tech and industrial companies. Amazon plans $150 billion investment over the next decade. |
Cloud Infrastructure Server Equipment Cooling Technology Power Infrastructure Capacity Expansion | |
EnergyAI and data centers are introducing a new era of energy demand, with estimates of 2-5% annual electricity load growth versus historical 0.4%. This creates opportunities for natural gas, nuclear power, utilities, and industrial companies across the energy supply chain. The manager increased energy sector exposure during the quarter. |
Power Generation Natural Gas Nuclear Electricity Demand Infrastructure | |
OnshoringReshoring of manufacturing back to the U.S. remains a strong theme supporting industrial companies. The manager views this as one of multiple reasons why the economy should continue to grow and sees it as a sustainable trend benefiting their industrial holdings. |
Manufacturing Supply Chain Domestic Production Industrial Policy Reshoring | |
| 2023 Q4 |
InflationManager believes inflation will continue to fall as key drivers (excess money supply, excess savings, supply chain issues) normalize. M2 money supply is now negative year-over-year, excess savings are declining, and supply chains have largely recovered. Labor shortages remain the biggest wildcard with tight employment markets. |
M2 Labor Supply Chain Wages Fed Policy |
OnshoringReshoring is identified as a powerful trend after decades of moving manufacturing overseas. Covid supply chain disruptions and uncertain behavior by China are driving companies to move manufacturing and supply chains back to the US, creating opportunities for industrial companies. |
Manufacturing Supply Chain China Covid Industrial | |
Infrastructure SpendingMultiple federal stimulus programs worth over $1 trillion offer opportunities including new infrastructure spending, Inflation Reduction Act, Rural Broadband programs, and Chips Act. These benefit engineering & construction, automation, machinery, EV suppliers, and renewable energy companies. |
Federal Stimulus Chips Act Broadband Construction Renewable Energy |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 | Fund Letters | Jeffrey James | PWR US | Quanta Services, Inc. | Industrials | Engineering & Construction | Bull | NYSE | backlog, Electrification, energy, Grid, growth, infrastructure, Margins | Login |
| Oct 14, 2025 | Fund Letters | Jeffrey James | CVNA US | Carvana Co. | Consumer Discretionary | Internet & Direct Marketing Retail | Bull | NYSE | Autos, cash flow, ecommerce, growth, leverage, restructuring, valuation | Login |
| Oct 14, 2025 | Fund Letters | Jeffrey James | GH US | Guardant Health, Inc. | Health Care | Diagnostics & Research | Bull | NASDAQ | Adoption, Biotech, diagnostics, FDA, growth, Oncology, Reimbursement | Login |
| Oct 14, 2025 | Fund Letters | Jeffrey James | AXON US | Axon Enterprise, Inc. | Industrials | Aerospace & Defense | Bull | NASDAQ | cloud, Defense, growth, law enforcement, Margins, recurring revenue, SaaS | Login |
| TICKER | COMMENTARY |
|---|---|
| TER | Teradyne, Inc. is listed as the top holding at 2.1% of the strategy in the Information Technology sector. |
| FTAI | FTAI Aviation Ltd. is listed as a top holding at 2.1% of the strategy in the Industrials sector. |
| PRAX | Praxis Precision Medicines, Inc. is listed as a top holding at 1.9% of the strategy in the Health Care sector. |
| CRS | Carpenter Technology Corporation is listed as a top holding at 1.8% of the strategy in the Industrials sector. |
| COHR | Coherent Corp. is listed as a top holding at 1.8% of the strategy in the Information Technology sector. |
| OWL | Blue Owl Capital, Inc. has been at the epicenter of concerns about private credit markets as it and others have seen elevated requests for withdrawals from their funds, especially from retail investors. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||